10-90912547-T-C

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_014391.3(ANKRD1):​c.*319A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00692 in 331,876 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.0059 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0078 ( 13 hom. )

Consequence

ANKRD1
NM_014391.3 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.122
Variant links:
Genes affected
ANKRD1 (HGNC:15819): (ankyrin repeat domain 1) The protein encoded by this gene is localized to the nucleus of endothelial cells and is induced by IL-1 and TNF-alpha stimulation. Studies in rat cardiomyocytes suggest that this gene functions as a transcription factor. Interactions between this protein and the sarcomeric proteins myopalladin and titin suggest that it may also be involved in the myofibrillar stretch-sensor system. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ANKRD1NM_014391.3 linkuse as main transcriptc.*319A>G 3_prime_UTR_variant 9/9 ENST00000371697.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ANKRD1ENST00000371697.4 linkuse as main transcriptc.*319A>G 3_prime_UTR_variant 9/91 NM_014391.3 P1

Frequencies

GnomAD3 genomes
AF:
0.00591
AC:
899
AN:
152154
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00179
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00793
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00559
Gnomad FIN
AF:
0.000943
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00951
Gnomad OTH
AF:
0.00718
GnomAD4 exome
AF:
0.00778
AC:
1397
AN:
179604
Hom.:
13
Cov.:
0
AF XY:
0.00791
AC XY:
769
AN XY:
97162
show subpopulations
Gnomad4 AFR exome
AF:
0.00168
Gnomad4 AMR exome
AF:
0.00450
Gnomad4 ASJ exome
AF:
0.00115
Gnomad4 EAS exome
AF:
0.000122
Gnomad4 SAS exome
AF:
0.00942
Gnomad4 FIN exome
AF:
0.00180
Gnomad4 NFE exome
AF:
0.00935
Gnomad4 OTH exome
AF:
0.00616
GnomAD4 genome
AF:
0.00591
AC:
900
AN:
152272
Hom.:
4
Cov.:
32
AF XY:
0.00569
AC XY:
424
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.00178
Gnomad4 AMR
AF:
0.00785
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00601
Gnomad4 FIN
AF:
0.000943
Gnomad4 NFE
AF:
0.00951
Gnomad4 OTH
AF:
0.00710
Alfa
AF:
0.00789
Hom.:
0
Bravo
AF:
0.00649
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1
Uncertain significance, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Primary dilated cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
7.7
DANN
Benign
0.49

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs142439928; hg19: chr10-92672304; API